Acute myeloid leukemia trials in Georgia

3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 1Enrolling by invitation
  A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

  Where

  Tbilisi

  Age

  18 years and over

  People

  120 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT06788509 · EU 2024-515457-21-00
• Phase 3Taking people
  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  Where

  Batumi, Tbilisi

  Age

  12 years and over

  People

  468 worldwide

  Run by

  Syndax Pharmaceuticals

  See details and how to joinNCT07211958 · EU 2025-522279-27-00
• Phase 2/3Taking people
  L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

  Where

  Tbilisi

  Age

  18 years to 80 years

  People

  312 worldwide

  Run by

  Moleculin Biotech, Inc.

  See details and how to joinNCT06788756 · EU 2024-518359-47-00